Clinical Takeaway Over a 15-year period, this Canadian cohort study tracked adolescents into early adulthood to understand how early risk factors like body image concerns and disordered eating contribute to mental health...
`Adolescent Cannabis Use and Mental Health: Clinical Evidence`
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These are...
endocannabinoid system clinical research: Eating Disorders
Clinical Takeaway The REAL 2.0 cohort study tracked Canadian youth over 15 years to examine how adolescent risk factors like body image concerns and disordered eating contribute to mental health, eating disorders,...
endocannabinoid system clinical research: REAL 2.0 Study
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image and disordered eating contribute to mental health and substance use outcomes...
Endocannabinoid System & Teen Mental Health: Clinical Evidence
Clinical Takeaway Adolescents with higher levels of depression and anxiety symptoms were more likely to initiate and use cannabis more frequently over the following 18 months, supporting the idea that young people...
Adolescent Cannabis Use: Mental Health Risks Examined
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These findings...
Adolescent Cannabis Use and Psychotic Disorder Risk
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These findings...
Adolescent Cannabis Use and Psychotic Disorder Risk
Clinical Takeaway Adolescent cannabis use is associated with increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large population-level longitudinal data tracking clinically diagnosed...
endocannabinoid system clinical research eating disorders
Clinical Takeaway The REAL 2.0 study followed Canadian youth for 15 years to examine how adolescent risk factors like body image concerns and disordered eating contribute to mental health and substance use...
A huge study finds a link between cannabis use in teens and psychosis later – WBAA
WHY IT MATTERS: If you are a parent, caregiver, or young adult patient, this research reinforces that cannabis therapies should be reserved for adults with clinical oversight, and that adolescent use without medical necessity carries real psychiatric risk. CLINICAL OVERVIEW: Large-scale research continues to reinforce what clinicians have observed for years: adolescent cannabis use is associated with increased risk of psychotic disorders, depression, and anxiety later in life. The developing brain, particularly before age 25, is uniquely vulnerable to the effects of THC on endocannabinoid system signaling, and early exposure may alter neurodevelopmental trajectories in ways that increase psychiatric risk.